These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23828638)

  • 1. High-resolution NMR spectroscopy of human body fluids and tissues in relation to prostate cancer.
    Kumar V; Dwivedi DK; Jagannathan NR
    NMR Biomed; 2014 Jan; 27(1):80-9. PubMed ID: 23828638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma.
    Averna TA; Kline EE; Smith AY; Sillerud LO
    J Urol; 2005 Feb; 173(2):433-8. PubMed ID: 15643195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR-based metabolomics approach to target biomarkers for human prostate cancer.
    Jordan KW; Cheng LL
    Expert Rev Proteomics; 2007 Jun; 4(3):389-400. PubMed ID: 17552923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic signatures of aggressive prostate cancer.
    McDunn JE; Li Z; Adam KP; Neri BP; Wolfert RL; Milburn MV; Lotan Y; Wheeler TM
    Prostate; 2013 Oct; 73(14):1547-60. PubMed ID: 23824564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics approaches and applications in prostate cancer research.
    Zhang A; Yan G; Han Y; Wang X
    Appl Biochem Biotechnol; 2014 Sep; 174(1):6-12. PubMed ID: 24838846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR-Based Prostate Cancer Metabolomics.
    Euceda LR; Andersen MK; Tessem MB; Moestue SA; Grinde MT; Bathen TF
    Methods Mol Biol; 2018; 1786():237-257. PubMed ID: 29786797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR-based metabolomics of prostate cancer: a protagonist in clinical diagnostics.
    Kumar D; Gupta A; Nath K
    Expert Rev Mol Diagn; 2016 Jun; 16(6):651-61. PubMed ID: 26959614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection.
    Kline EE; Treat EG; Averna TA; Davis MS; Smith AY; Sillerud LO
    J Urol; 2006 Nov; 176(5):2274-9. PubMed ID: 17070311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidimensional MR spectroscopic imaging of prostate cancer in vivo.
    Thomas MA; Nagarajan R; Huda A; Margolis D; Sarma MK; Sheng K; Reiter RE; Raman SS
    NMR Biomed; 2014 Jan; 27(1):53-66. PubMed ID: 23904127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions.
    Serkova NJ; Gamito EJ; Jones RH; O'Donnell C; Brown JL; Green S; Sullivan H; Hedlund T; Crawford ED
    Prostate; 2008 May; 68(6):620-8. PubMed ID: 18213632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis in magnetic resonance spectroscopy: from metabolic profiling to in vivo biomarkers.
    Serkova NJ; Brown MS
    Bioanalysis; 2012 Feb; 4(3):321-41. PubMed ID: 22303835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
    Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
    J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA biomarkers in body fluids of prostate cancer patients.
    Kuner R; Brase JC; Sültmann H; Wuttig D
    Methods; 2013 Jan; 59(1):132-7. PubMed ID: 22652624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer.
    Hasumi M; Suzuki K; Oya N; Ito K; Kurokawa K; Fukabori Y; Yamanaka H
    Anticancer Res; 2002; 22(2B):1205-8. PubMed ID: 12168926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia.
    Komoroski RA; Holder JC; Pappas AA; Finkbeiner AE
    Magn Reson Med; 2011 Apr; 65(4):911-3. PubMed ID: 20967792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative NMR-Based Metabolomics on Tissue Biomarkers and Its Translation into In Vivo Magnetic Resonance Spectroscopy.
    Serkova NJ; Davis DM; Steiner J; Agarwal R
    Methods Mol Biol; 2019; 1978():369-387. PubMed ID: 31119675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear magnetic resonance spectroscopy of human body fluids and in vivo magnetic resonance spectroscopy: Potential role in the diagnosis and management of prostate cancer.
    Gholizadeh N; Pundavela J; Nagarajan R; Dona A; Quadrelli S; Biswas T; Greer PB; Ramadan S
    Urol Oncol; 2020 Apr; 38(4):150-173. PubMed ID: 31937423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance spectroscopic studies of the prostate.
    Koutcher JA; Zakian K; Hricak H
    Mol Urol; 2000; 4(3):143-52;discussion 153. PubMed ID: 11062368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in nuclear magnetic resonance spectroscopy for early cancer diagnosis].
    Gao XX; Xu YZ; Zhao MX; Qi J; Li HZ; Wu JG
    Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Aug; 28(8):1942-50. PubMed ID: 18975839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.